You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-BCAR1 antibody (ab80016)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-BCAR1 antibody
See all BCAR1 products (17) ...

Description

Rabbit polyclonal to BCAR1

Tested applications

WB, ICC/IFmore details

Cross reactivity

Reacts with

Human

Predicted to work with

Mouse, Rat, Cow, Zebrafish

Immunogen

Synthetic peptide conjugated to KLH derived from within residues 1 - 100 of Human BCAR1.

(Peptide available as ab89387.)

Positive control

This antibody gave a positive signal in the following tissue lysates: Human Brain; Human Testis; Human Liver. Whole cell lysates: MBA MD 231; MDA MB 361; MCF7; T47D.

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: 0.02% Sodium Azide
Constituents: 1% BSA, PBS, pH 7.4

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Clonality

Polyclonal

Isotype

IgG

  • Western blot - BCAR1 antibody (ab80016)Western blot - BCAR1 antibody (ab80016) image (enlarge)

  • Immunocytochemistry/ Immunofluorescence - BCAR1 antibody (ab80016)Immunocytochemistry/ Immunofluorescence - BCAR1 antibody (ab80016) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab80016 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Docking protein which plays a central coordinating role for tyrosine-kinase-based signaling related to cell adhesion. Implicated in induction of cell migration. Overexpression confers antiestrogen resistance on breast cancer cells.

Tissue specificity

Widely expressed with an abundant expression in the testis. Low level of expression seen in the liver, thymus, and peripheral blood leukocytes. The protein has been detected in a B-cell line.

Sequence similarities

Belongs to the CAS family.
Contains 1 SH3 domain.

Domain

Contains a central domain (substrate domain) containing multiple potential SH2-binding sites and a C-terminal domain containing a divergent helix-loop-helix (HLH) motif. The SH2-binding sites putatively bind CRK, NCK and ABL SH2 domains. The HLH motif is absolutely required for the induction of pseudohyphal growth in yeast and mediates heterodimerization with CASL.
A serine-rich region promotes activation of the serum response element (SRE).
The SH3 domain is necessary for the localization of the protein to focal adhesions and interacts with one proline-rich region of focal adhesion kinase 1.

Post-translational
modifications

Focal adhesion kinase 1 phosphorylates the protein at the YDYVHL motif. SRC-family kinases are recruited to the phosphorylated sites and can phosphorylate other tyrosine residues. Tyrosine phosphorylation is triggered by integrin mediated adhesion of cells to the extracellular matrix.

Cellular localization

Cell junction > focal adhesion. Cytoplasm. Unphosphorylated form localizes in the cytoplasm and can move to the membrane upon tyrosine phosphorylation.

Target information above from: UniProt accessionP56945 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • Breast cancer anti estrogen resistance 1 protein antibody
  • BCAR 1 antibody
  • Bcar1 antibody
  • BCAR1_HUMAN antibody
  • Breast cancer anti estrogen resistance 1 antibody
  • Breast cancer anti-estrogen resistance protein 1 antibody
  • CAS antibody
  • Cas scaffolding protein family member 1 antibody
  • Crk associated substrate antibody
  • Crk associated substrate p130Cas antibody
  • CRK-associated substrate antibody
  • CRKAS antibody
  • P130CAS antibody
see all

Anti-BCAR1 antibody images:

  Western blot - BCAR1 antibody (ab80016)

Western blot - BCAR1 antibody (ab80016)

All lanes : Anti-BCAR1 antibody (ab80016) at 1 µg/ml

Lane 1 : Breast (Human) Tissue Lysate - normal tissue (ab30090)
Lane 2 : Testis (Human) Tissue Lysate - adult normal tissue (ab30257)
Lane 3 : Liver (Human) Tissue Lysate - adult normal tissue (ab29889)
Lane 4 : MDA-MB-231 (Human breast adenocarcinoma cell line) Whole Cell Lysate
Lane 5 : MDA-MB-361 (Human breast adenocarcinoma cell line) Whole Cell Lysate
Lane 6 : MCF7 (Human breast adenocarcinoma cell line) Whole Cell Lysate
Lane 7 : T47D (Human ductal breast epithelial tumor cell line) Whole Cell Lysate (ab14899)

Lysates/proteins at 10 µg per lane.

Secondary
Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
developed using the ECL technique

Performed under reducing conditions.

Predicted band size : 93 kDa
Observed band size : 100 kDa (why is the actual band size different from the predicted?)
Additional bands at : 37 kDa,50 kDa. We are unsure as to the identity of these extra bands.

Exposure time : 30 seconds

Breast cancer anti-estrogen resistance protein 1 (BCAR1) contains a number of potential phosphorylation sites (SwissProt) which may explain its migration at a higher (100 kDa) molecular weight than predicted (93 kDa).

  Immunocytochemistry/ Immunofluorescence - BCAR1 antibody (ab80016)

Immunocytochemistry/ Immunofluorescence - BCAR1 antibody (ab80016)

ICC/IF image of ab80016 stained HeLa cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal Goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab80016, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 Goat anti-Rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM. This antibody also gave a positive result in 4% PFA fixed (10 min) HEK293, HepG2, and MCF-7 cells at 1µg/ml, and in 100% Methanol fixed (5 min) HeLa, HEK293, HepG2, and MCF-7 cells at 1µg/ml.

References for Anti-BCAR1 antibody (ab80016)

ab80016 has not yet been referenced specifically in any publications.

Publishing research using ab80016? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"